Rixos Premium Dubai’s signature all-day dining concept, Turquoise, has long been a staple among discerning guests. Building on its reputation for delivering exceptional globally inspired dining experiences, the restaurant was recently awarded first place in the prestigious Food Elite Program at the annual Dubai International Food Safety Conference (DIFSC). The win highlights Turquoise’s continued focus […] The post Rixos Premium Dubai’s Turquoise Restaurant Wins First Place in Dubai Municipality Food Elite Program appeared first on Web-Release.

Esterad Investment Co. B.S.C. (“Esterad” or the “Company”) (Trading Code: ESTERAD) today announced its financial results for the fourth quarter of 2025 (the “Quarter”) and the full year ended 31 December 2025 (the “Year”), delivering solid growth in profitability and reinforcing the Company’s strategic momentum across its diversified investment platform. Net Profit attributable to shareholders […] The post “ESTERAD Reports BD 6.75 million Profits for 2025” Achieved 10% YoY Increase in Net Profit Attributable to the Shareholders & Board Recommended Distribution of 15% of the Capital appeared first on Web-Release.

Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.